Top Markets
#1 BSquared Network BSquared Network +96.19%
#2 Akedo Akedo +33.46%
#3 Derive Derive +33.21%
#4 DogBull DogBull +31.24%
#5 Zama Zama +27.76%
#6 Arweave Arweave +24.51%
#7 MetaDAO MetaDAO +20.80%
#8 Harmony Harmony +16.97%
#9 Cortex Cortex +16.52%
#10 Synapse Synapse +16.16%
Coin of the day
BSquared Network BSquared Network
Tetapan
Bahasa
MALAY
Mata wang
USD
Tema
Gilead Sciences, Inc. Gilead Sciences, Inc.

Gilead Sciences, Inc.

GILD
Kedudukan dalam Saham #100
Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations... Gilead Sciences, Inc. is a global biopharmaceutical enterprise, with operations spanning the United States, Europe, and numerous international markets. Its core mission involves discovering, developing, and commercializing innovative medications to address critical health needs. The company's extensive product portfolio encompasses treatments for a variety of severe conditions. For HIV/AIDS, it supplies key therapies such as Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/Eviplera, Stribild, and Atripla. In response to the 2019 coronavirus pandemic, Gilead provides Veklury, an injectable drug for intravenous administration. Its offerings for liver diseases include Epclusa, Harvoni, Vosevi, Vemlidy, and Viread. Furthermore, Gilead assists patients battling hematological disorders, various cancers, and those undergoing cell therapy, through products like Yescarta, Tecartus, Trodelvy, and Zydelig. Other specialized medicines include Letairis, an oral drug for pulmonary arterial hypertension; Ranexa, also an oral medication, for chronic angina; and AmBisome, a liposomal formulation designed to combat serious invasive fungal infections. Gilead Sciences, Inc. actively engages in collaboration agreements with a diverse range of partners to advance its therapeutic pipeline. These include Arcus Biosciences, Inc., Pionyr Immunotherapeutics Inc., Tizona Therapeutics, Inc., Tango Therapeutics, Inc., Jounce Therapeutics, Inc., Galapagos NV, Janssen Sciences Ireland Unlimited Company, Japan Tobacco, Inc., Gadeta B.V., Bristol-Myers Squibb Company, Dragonfly Therapeutics, Inc., and Merck & Co, Inc. The company was founded in 1987 and its corporate headquarters are situated in Foster City, California.
Harga Saham
$150.78
Disegerakkan terakhir: 2026-09-18
Modal Pasaran
$187.20B
Perubahan (1 hari)
-0.08%
Perubahan (1 tahun)
32.15%
Negara
US
Perdagangan Gilead Sciences, Inc. (GILD)

Kategori

Healthcare
Nisbah P/B bagi Gilead Sciences, Inc. (GILD)
Nisbah P/B pada September 2026 TTM: 15.39
Menurut laporan kewangan dan harga saham terkini Gilead Sciences, Inc., nisbah P/B semasa (TTM) ialah 15.39. Pada akhir 2024, nisbah P/B syarikat ialah 5.96.
Sejarah nisbah P/B untuk Gilead Sciences, Inc. dari 2000 hingga 2026
Nisbah P/B pada akhir setiap tahun
Tahun Nisbah P/B Ubah
2026 (TTM) 15.39 -100.00%
2025 0.00 -100.00%
2024 5.96 34.58%
2023 4.43 -12.71%
2022 5.07 17.19%
2021 4.33 7.59%
2020 4.02 9.82%
2019 3.66 -3.49%
2018 3.80 -17.12%
2017 4.58 -9.78%
2016 5.08 -36.48%
2015 7.99 -14.05%
2014 9.30 -7.89%
2013 10.10 68.83%
2012 5.98 27.09%
2011 4.71 -11.06%
2010 5.29 -13.96%
2009 6.15 -44.20%
2008 11.02 -10.79%
2007 12.35 -24.75%
2006 16.42 108.13%
2005 7.89 -2.41%
2004 8.08 -30.89%
2003 11.69 0.49%
2002 11.64 -15.83%
2001 13.83 28.66%
2000 10.75 0.00%
Nisbah P/B untuk syarikat atau pesaing yang serupa
Syarikat Nisbah P/B Perbezaan Nisbah P/B Negara
Eli Lilly and Company Eli Lilly and Company
Eli Lilly and Company
LLY.US
 29.9692 94.78%
US
Johnson & Johnson Johnson & Johnson
Johnson & Johnson
JNJ.US
 7.6479 -50.29%
US
AbbVie Inc. AbbVie Inc.
AbbVie Inc.
ABBV.US
 -78.0908 -607.54%
US
Roche Holding AG Roche Holding AG
Roche Holding AG
RO.SW
 8.4776 -44.90%
CH
Merck & Co., Inc. Merck & Co., Inc.
Merck & Co., Inc.
MRK.US
 8.5385 -44.51%
US